Inflammatory condition around an osseointegrated or functional implant characterized by soft‑tissue inflammation and progressive loss of supporting peri‑implant bone beyond initial adaptive remodeling, commonly associated with bleeding on probing and radiographic bone loss.

Principle

Peri‑implantitis develops when a persistent biofilm and host inflammatory response, mechanical overload, or other local/systemic modifiers induce a destructive process in peri‑implant tissues such that bone loss progresses beyond the physiologic remodeling phase; it is distinct from peri‑implant mucositis, which lacks bone loss.

Demonstration

Illustrative scenario: during routine follow‑up a patient’s implant shows bleeding on probing and a radiograph reveals crestal bone loss compared with earlier images. Clinical recognition prompts identification of local factors (plaque, prosthetic fit, occlusal load), non‑surgical decontamination or surgical access as indicated, and an individualized maintenance plan to arrest progression.

Misapplication

Conflating peri‑implant mucositis with peri‑implantitis is a common semantic error; mucositis denotes reversible soft‑tissue inflammation without radiographic bone loss, while peri‑implantitis requires evidence of progressive bone loss.

Consequence

When peri‑implantitis is unrecognized or unmanaged it can lead to continued bone loss, loss of implant stability and function, need for surgical intervention or implant removal, and increased complexity and cost of rehabilitation.

Reversal

The diagnostic principle is qualified by the early post‑surgical remodeling period—initial crestal bone changes after implant placement are physiological and do not constitute peri‑implantitis; diagnosis of disease requires change beyond the remodeling baseline and correlation with clinical signs.

Boundary

Clearly within: sites with clinical inflammation and radiographic progressive crestal bone loss adjacent to an implant. Boundary case: increased probing depth with bleeding but no radiographic bone change—may represent mucositis or early disease depending on trend. Clearly outside: inflammatory or infectious processes affecting natural teeth (periodontitis) not directly related to the implant.

Semantic Tension

Preservation of implant function versus surgical/biologic cost: aggressive surgical interventions can arrest peri‑implant bone loss but carry morbidity and cost, so clinicians must balance invasiveness against likelihood of disease progression and patient factors.

Synthesis

Peri‑implantitis is a biologically driven, site‑specific disease process distinguished by inflammation plus progressive bone loss; effective management depends on early detection, removal or control of local drivers and tailoring interventions to the stage and modulating host or biomechanical factors.